| Literature DB >> 21254737 |
C R Popescu1, S V G Bertesteanu, D Mirea, Raluca Grigore, Diana lonescu, B Popescu.
Abstract
At the beginning of the 21st century the hypopharynx and the cervical esophagus cancer represents a major issue for all countries of the world. The epidemiology of the hypopharynx and cervical esophagus cancer deals with the spread of the disease in the human population with regard to sex, age, profession, time and space, as well as risk factors that contribute to these phenomena. The main goal is to investigate the causes and the factors involved in the development of the tumors at the pharyngoesophageal junction, knowledge that contributes to the latest therapeutic assessment through interdisciplinary collaboration (E.N.T. surgeon, general surgeon, radiation oncologist, chemotherapist, and nutritionist). The epidemiology of the hypopharynx and cervical esophagus cancer includes three major areas of interest: descriptive (the study of the spread in mass population), analytical (the study of causal risk factors on the disease) and experimental (that verifies by experiments on animals the prior identified hypothesis).Entities:
Mesh:
Year: 2010 PMID: 21254737 PMCID: PMC3019060
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Appearance rate on 100,000 persons/year of hypopharynx cancer regarding sex and rase (after Canto and Devesa 2002).
| Sex-Rase/ Location | Hypopharynx | Piriform sinus |
|---|---|---|
| White male | 0.4 | 0.9 |
| Black male | 0.8 | 2,3 |
| White women | 0.2 | 0.2 |
| Black women | 0.2 | 0.5 |
Association between pharynx cancer and exposure to asbestos fibers and tobacco (RR – relative risk, CI – trust interval)(modified after Committee on Asbestos: Selected Health Effects 2006).
| Study | Smoking history (packs/year) | RR with 95% CI for asbestos exposure | |
|---|---|---|---|
| None / Small | Intermediate /High | ||
| Marchand et al. (2000) (adjusted on age and alcohol consumption) | < 30 | 1.0 | 1.2 (0.6 – 2.3) |
| 30 + | 4.0 (2.2 – 7.2) | 6.2 (3.4 – 11.4) |
Genetic modifications in squamous esophageal carcinoma (modified after Hamilton SR, Aaltonen LA, Pathology and Genetics of Tumors of the Digestive System, OMS, IACRS 2000, 11–19).
| Genes | Location | Tumor abnormality | Function |
|---|---|---|---|
| DLC1 | 8p21.3 | Transcription stopping | Growth factor |
| FEZ1 | 8p22 | Transcription stopping | Transcription factor |
| c–myc | 8q24.1 | Amplification | Transcription factor |
| p16, p15, ARF/CDN2 | 9p22 | Homozygous inhibition | CDK inhibitor (cellular cycle control) |
| Cyclin D1 | 11q13 | Amplification | Cellular cycle control |
| RB | 13q14 | LOH, absence of expression | Cellular cycle control |
| TP53 | 17p13 | Punctiform mutation, LOH | Apoptosis, genetic stability, G1 stopping |
| EGFR | 17p13 | Amplification, over on | Transduction signal |
| TOC | 17q25 | LOH | Transduction signal |